Home Am I at Risk? Other Heart Disease - AFib

Other Heart Disease - AFib

Atrial Fibrillation

Atrial fibrillation is an extremely important risk factor for stroke in women. For information on atrial fibrillation and how it can put you at risk for stroke, see our complete article on atrial fibrillation and stroke risk.

References

  1. Rosamond W, Flegal K, Friday G, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. February 6 2007;115(5):e69-171.
  2. Tanne D, Shotan A, Goldbourt U, et al. Severity of Angina Pectoris and Risk of Ischemic Stroke. Stroke. January 1, 2002 2002;33(1):245-250.
  3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. Sep 8 1998;98(10):946-952.
  4. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic Peripheral Arterial Disease Is Independently Associated With Impaired Lower Extremity Functioning : The Women’s Health and Aging Study. Circulation. March 7, 2000 2000;101(9):1007-1012.
  5. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. Mar 21 2006;113(11):e463-654.
  6. Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. May 1997;131(1):115-125.
  7. Becker GJ, McClenny TE, Kovacs ME, Raabe RD, Katzen BT. The importance of increasing public and physician awareness of peripheral arterial disease. J Vasc Interv Radiol. Jan 2002;13(1):7-11.
  8. American Heart Association. Women and Cardiovascular Diseases - Statistics. Dallas, TX: American Heart Association; 2007.
  9. Rosamond W, Flegal K, Furie K, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. January 29, 2008 2008;117(4):e25-146.
  10. Hunt SA. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. September 20, 2005 2005;46(6):e1-82.
  11. Witt BJ, Gami AS, Ballman KV, et al. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. J Card Fail. Aug 2007;13(6):489-496.
  12. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. Jan 23 1997;336(4):251-257.
  13. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, for the PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation. June 4 2002;105(22):2625-2631.
  14. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. Nov 29 2007;357(22):2262-2268.
  15. Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol. Jan 1999;15(1):57-64.
  16. Meissner I, Khandheria BK, Heit JA, et al. Patent Foramen Ovale: Innocent or Guilty?: Evidence From a Prospective Population-Based Study. J Am Coll Cardiol. January 17 2006;47(2):440-445.
  17. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent Foramen Ovale and the Risk of Ischemic Stroke in a Multiethnic Population. J Am Coll Cardiol. February 20 2007;49(7):797-802.
  18. Furlan AJ. Patent foramen ovale and stroke: to close or not to close? Cleve Clin J Med. Feb 2007;74 Suppl 1:S118-120.
  19. Allareddy V, Ward MM, Ely JW, Levett J. Impact of complications on outcomes following aortic and mitral valve replacements in the United States. J Cardiovasc Surg (Torino). Jun 2007;48(3):349-357.
  20. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. Aug 1 2006;114(5):e84-231.
  21. Petty GW, Khandheria BK, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Predictors of Cerebrovascular Events and Death Among Patients With Valvular Heart Disease : A Population-Based Study. Stroke. November 1, 2000 2000;31(11):2628-2635.
  22. Turpie A, Gent M, Laupacis A, et al. A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement. N Engl J Med. August 19 1993;329(8):524-529.

Filed in Am I at Risk? > Featured


SEO by AceSEF
Banner
Banner